Healthcare Remains the Core Catalyst: The primary market driver continues to be the clinical demand for neurorehabilitation, motor recovery, and speech restoration for patients with ALS, stroke, spinal cord injuries, and neurodegenerative disorders.
AI & Software Drive Value Creation: While implantable hardware and electrode arrays command high upfront costs, software—powered by AI and machine learning—serves as the primary engine for long-term scalability and recurring revenue models.